Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
03/26/2009 | US20090082554 Thiocarbonate linkers for polynucleotides |
03/26/2009 | US20090082410 Constitutively translocating cell line |
03/26/2009 | US20090082302 Modulation of eif4e-bp2 expression |
03/26/2009 | US20090082300 Modulation of transthyretin expression |
03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
03/26/2009 | US20090082294 Diagnosis, prevention and treatment of cancer |
03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
03/26/2009 | US20090082289 Adenoviral vectors having a protein IX deletion |
03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
03/26/2009 | US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
03/26/2009 | US20090082225 Nucleic acid archiving |
03/26/2009 | US20090082212 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
03/26/2009 | US20090081788 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
03/26/2009 | US20090081785 Desiccated Biologics And Methods Of Preparing The Same |
03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
03/26/2009 | US20090081779 Tumor suppressor gene, p28ing5 |
03/26/2009 | US20090081772 Method and device for collecting cellular material from cells isolated on a filter |
03/26/2009 | US20090081759 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long |
03/26/2009 | US20090081754 Gene of enzyme having activity to generate lachrymatory factor |
03/26/2009 | US20090081737 Methods and compositions for reducing the complexity of a nucleic acid sample |
03/26/2009 | US20090081732 Antibodies to human il-1beta |
03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
03/26/2009 | US20090081727 CD33-Like Protein |
03/26/2009 | US20090081725 Compositions of pamps and Listeria monocytogenes and methods of use |
03/26/2009 | US20090081687 Nucleic Acid Molecules and Other Molecules Associated with Plants |
03/26/2009 | US20090081678 Nucleic acid isolation in preserved whole blood |
03/26/2009 | US20090081677 Method for gender identification of eagles with probe-based real-time pcr and the sequences used for gender identification of eagles |
03/26/2009 | US20090081676 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
03/26/2009 | US20090081673 Platensimycin biosynthetic gene cluster of streptomyces platensis |
03/26/2009 | US20090081657 Genetic Identification And Validation Of Echinacea Species |
03/26/2009 | US20090081654 Transfection kinetics and structural promoters |
03/26/2009 | US20090081653 A nucleic acid regulating the expression of a gene responsive to insulin where the nucleic acid hybridizes under moderate stringency conditions to a hybridization probe; obesity; insulin-resistance syndrome; antidiabetic and -proliferative |
03/26/2009 | US20090081652 Constitutively Translocating Cell Line |
03/26/2009 | US20090081651 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES |
03/26/2009 | US20090081646 Universal primers and their use for detecting and identifying plant materials in complex mixtures |
03/26/2009 | US20090081642 Novel apoptosis gene EI24, compositions, and methods of use |
03/26/2009 | US20090081354 Phytate Polynucleotides and Methods of Use |
03/26/2009 | US20090081331 Phytase |
03/26/2009 | US20090081274 Mast cell-derived renin |
03/26/2009 | US20090081256 Transgenic plant-based vaccines |
03/26/2009 | US20090081248 Non-hemolytic LLO fusion proteins and methods of utilizing same |
03/26/2009 | US20090081243 Agents and methods for diagnosing stress |
03/26/2009 | US20090081237 Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents |
03/26/2009 | US20090081230 Human cytomegalovirus neutralising antibodies and use thereof |
03/26/2009 | US20090081229 Anti-pro87299 antibodies |
03/26/2009 | US20090081228 Cyr61 compositions and methods |
03/26/2009 | US20090081218 Fusion proteins |
03/26/2009 | US20090081210 Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells |
03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
03/26/2009 | US20090081202 Immunogenic compositions and methods |
03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
03/26/2009 | US20090081144 Cosmetic compositions |
03/26/2009 | US20090081124 Virus coat protein/receptor chimeras and methods of use |
03/26/2009 | US20090078574 Charge tags and the separation of nucleic acid molecules |
03/26/2009 | CA2697532A1 Method of amplifying nucleic acid |
03/26/2009 | CA2694494A1 Hpiv-2 variants and medical applications thereof |
03/25/2009 | EP2039774A1 Methods for the production of products in host cells |
03/25/2009 | EP2039762A2 Nitralases |
03/25/2009 | EP2039251A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
03/25/2009 | EP2038428A1 Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase |
03/25/2009 | EP2038427A2 Single-molecule pcr on microparticles in water-in-oil emulsions |
03/25/2009 | EP2038418A2 Dna molecules and methods |
03/25/2009 | EP2038409A2 Novel human acidic mammalian chitinase and use thereof |
03/25/2009 | EP2038405A2 Methods and systems for increasing production of equilibrium reactions |
03/25/2009 | EP2037960A2 Methods for manipulating stem cells |
03/25/2009 | EP1641810A4 Prediction of likelihood of cancer recurrence |
03/25/2009 | EP1615942A4 Polymerase inhibitor and method of using same |
03/25/2009 | EP1539791A4 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
03/25/2009 | EP1499748B1 Hepatitis c virus assay systems |
03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
03/25/2009 | CN101395169A Buffers for detection of mRNA separated in a microfluidic device |
03/25/2009 | CN101392249A Antibiotic peptide gene, preparation method thereof and construction of expression plasmid of the same in pichia vector |
03/25/2009 | CN100471864C Method for preparing standard reference for qualitative, quantitative DNA |
03/25/2009 | CN100471863C Genetic markers for obesity |
03/25/2009 | CN100471862C Antisense oligonucleotides that inhibit expression of HIF-1 |
03/25/2009 | CN100471861C Rapid extraction of RNA from cells and tissues |
03/25/2009 | CN100471522C Polynucleotide compsn. method of prepn. and use thereof |
03/24/2009 | US7507876 regulatory polynucleotide isolated from Nicotiana tabacum, Arabidopsis thaliana, and Medicago truncatula useful for modulating transgene expression in plants; herbicide resistance |
03/24/2009 | US7507873 Transforming oviduct tissue of birds with nucleotide sequences coding mammalian polypeptides; bioreactors and heterologous gene expression; tissue engineering |
03/24/2009 | US7507811 siRNA targeting KRAS |
03/24/2009 | US7507810 Compositions and their uses directed to IL-4R alpha |
03/24/2009 | US7507809 RNAi modulation of RSV and therapeutic uses thereof |
03/24/2009 | US7507808 Modulation of endothelial lipase expression |
03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
03/24/2009 | US7507806 Nucleic acid sequences of human Rif1 |
03/24/2009 | US7507805 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
03/24/2009 | US7507804 Peptides and nucleic acid sequences related to the Epstein Barr Virus |
03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
03/24/2009 | US7507802 inducing immune activation of T-helper 1 type; anti-cancer treatments; bacteria is Escherichia coli or mycobacteria; synergistic mixture |
03/24/2009 | US7507801 therapies and screening methods for a variety of disorders including but not limited to: myeloid malignancies such as acute myelogenous leukemia, myelodysplastic syndrome, polycythemia vera and juvenile chronic myelogenous leukemia; autoimmune diso |
03/24/2009 | US7507800 Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination |
03/24/2009 | US7507793 Mammalian sweet taste receptors t1r3 |
03/24/2009 | US7507792 MDA-7 proteins and methods of use thereof |
03/24/2009 | US7507789 Detection of Anaplasma platys |
03/24/2009 | US7507752 A C9-deoxomeridamycin, used as a neuroregenerative agent |
03/24/2009 | US7507580 Ztnfr14, a tumor necrosis factor receptor |
03/24/2009 | US7507576 Method of manufacturing probe carrier |
03/24/2009 | US7507574 Recombinant Saccharomyces cerevisiae expressing chimeric glucose transporters |
03/24/2009 | US7507570 Recombinant chondroitinase ABC I and uses thereof |